89 related articles for article (PubMed ID: 7902235)
41. Reductive-oxygenation mechanism of metabolism of carbon tetrachloride to phosgene by cytochrome P-450.
Pohl LR; Schulick RD; Highet RJ; George JW
Mol Pharmacol; 1984 Mar; 25(2):318-21. PubMed ID: 6700577
[TBL] [Abstract][Full Text] [Related]
42. Nitric oxide formation during the cytochrome P-450-dependent reductive metabolism of 18-nitro-oxyandrostenedione.
Delaforge M; Piffeteau A; Boucher JL; Viger A
J Pharmacol Exp Ther; 1995 Aug; 274(2):634-40. PubMed ID: 7636722
[TBL] [Abstract][Full Text] [Related]
43. The role of mammalian intestinal bacteria in the reductive metabolism of zonisamide.
Kitamura S; Sugihara K; Kuwasako M; Tatsumi K
J Pharm Pharmacol; 1997 Mar; 49(3):253-6. PubMed ID: 9231340
[TBL] [Abstract][Full Text] [Related]
44. Effects of endogenous steroids on CYP3A4-mediated drug metabolism by human liver microsomes.
Nakamura H; Nakasa H; Ishii I; Ariyoshi N; Igarashi T; Ohmori S; Kitada M
Drug Metab Dispos; 2002 May; 30(5):534-40. PubMed ID: 11950784
[TBL] [Abstract][Full Text] [Related]
45. [Interaction of 8-aza-16-oxasteroids with rat liver microsomal cytochrome P-450].
Akhrem AA; Popova EM; Bokut' SB; Lis LG; Lakhvich FA
Biokhimiia; 1984 Apr; 49(4):570-6. PubMed ID: 6733160
[TBL] [Abstract][Full Text] [Related]
46. The reductive metabolism of the nitroaromatic flukicidal agent nitroxinil by liver microsomal cytochrome P-450.
Maffei Facino R; Pitrè D; Carini M
Farmaco Sci; 1982 Jul; 37(7):463-74. PubMed ID: 7128805
[TBL] [Abstract][Full Text] [Related]
47. Alterations in hepatic microsomal cytochrome P-450 hemeproteins in diabetic rats.
Past MR; Cook DE
Res Commun Chem Pathol Pharmacol; 1980 Feb; 27(2):329-37. PubMed ID: 6768119
[TBL] [Abstract][Full Text] [Related]
48. Reductive dechlorination of chloramphenicol by rat liver microsomes.
Morris PL; Burke TR; Phol LR
Drug Metab Dispos; 1983; 11(2):126-30. PubMed ID: 6133716
[TBL] [Abstract][Full Text] [Related]
49. Reductive metabolism of p,p'-DDT and o,p'-DDT by rat liver cytochrome P450.
Kitamura S; Shimizu Y; Shiraga Y; Yoshida M; Sugihara K; Ohta S
Drug Metab Dispos; 2002 Feb; 30(2):113-8. PubMed ID: 11792678
[TBL] [Abstract][Full Text] [Related]
50. [125I-n-iodophenamine as a prototype compound for the study of microsomal oxidation].
Kendysh IN; Bratsev VA; Gol'tiapin IuV; Klimova TV; Smirnova TN
Vopr Med Khim; 1988; 34(5):66-72. PubMed ID: 3218143
[TBL] [Abstract][Full Text] [Related]
51. D-penicillamine metabolism: in vitro studies of S-oxidation mechanisms.
Pilkington AE; Waring RH
Drug Metabol Drug Interact; 1988; 6(1):85-93. PubMed ID: 3234004
[TBL] [Abstract][Full Text] [Related]
52. General pharmacology of the novel antiepileptic compound zonisamide. 1st communication: effects on central nervous system.
Hori M; Ito T; Oka M; Noda Y; Matsuno Y; Furukawa K; Ochi Y; Karasawa T; Kadokawa T
Arzneimittelforschung; 1987 Oct; 37(10):1124-30. PubMed ID: 3435583
[TBL] [Abstract][Full Text] [Related]
53. Reductive metabolism of halothane by human and rabbit cytochrome P-450. Binding of 1-chloro-2,2,2-trifluoroethyl radical to phospholipids.
Trudell JR; Bösterling B; Trevor AJ
Mol Pharmacol; 1982 May; 21(3):710-7. PubMed ID: 7110119
[No Abstract] [Full Text] [Related]
54. Zonisamide: chemistry, mechanism of action, and pharmacokinetics.
Leppik IE
Seizure; 2004 Dec; 13 Suppl 1():S5-9; discussion S10. PubMed ID: 15511691
[TBL] [Abstract][Full Text] [Related]
55. Pharmacokinetic interaction of zonisamide in rats. Effect of other antiepileptics on zonisamide.
Kimura M; Tanaka N; Kimura Y; Miyake K; Kitaura T; Fukuchi H
J Pharmacobiodyn; 1992 Nov; 15(11):631-9. PubMed ID: 1289498
[TBL] [Abstract][Full Text] [Related]
56. Pharmacokinetics of mirodenafil, a new erectogenic, and its metabolite, SK3541, in rats: involvement of CYP1A1/2, 2B1/2, 2D subfamily, and 3A1/2 for the metabolism of both mirodenafil and SK3541.
Choi YH; Lee YS; Lee MG; Kim TK; Lee BY
J Pharm Pharm Sci; 2010; 13(1):93-106. PubMed ID: 20456834
[TBL] [Abstract][Full Text] [Related]
57. Reductive titration of cytochrome P-450 in rat liver microsomes.
Cooper DY; Cannon MD; Schleyer H; Rosenthal O
J Biol Chem; 1977 Jul; 252(14):4755-7. PubMed ID: 873914
[TBL] [Abstract][Full Text] [Related]
58. [Alar metabolism in the rat liver].
Avakian AKh; Marukhian AD
Farmakol Toksikol; 1982; 45(4):81-3. PubMed ID: 7128795
[No Abstract] [Full Text] [Related]
59. [The effect of adjuvant arthritis on the properties of the liver mono-oxygenase system in the rat].
Kameníková L; Elis J
Cesk Farm; 1981 Nov; 30(9):290-3. PubMed ID: 7317952
[No Abstract] [Full Text] [Related]
60. Extremely high drug-reductase activity based on aldehyde oxidase in monkey liver.
Kitamura S; Ohashi KNK ; Sugihara K; Hosokawa R; Akagawa Y; Ohta S
Biol Pharm Bull; 2001 Jul; 24(7):856-9. PubMed ID: 11456132
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
